Previous 10 | Next 10 |
Upon completion of first closing, Stavros Vizirgianakis to become Non-Executive Chairman BELGRADE, Mont., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spin...
Xtant Medical Holdings, Inc. (XTNT) Q2 2022 Earnings Conference Call August 04, 2022 09:00 AM ET Company Participants Matt Steinberg - IR, Lazar FINN Partners Sean Browne - President and CEO Scott Neils - CFO Conference Call Participants Presentatio...
Xtant Medical press release ( NYSE: XTNT ): Q2 GAAP EPS of -$0.02. Revenue of $15.28M (+2.0% Y/Y). Gross margin for the second quarter of 2022 was 54.8%, compared to 63.5% for the same period in 2021. The decrease is primarily attributable higher product costs and incr...
BELGRADE, Mont., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30...
BELGRADE, Mont., July 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter e...
Xtant Medical Holdings, Inc. (XTNT) Q1 2022 Earnings Conference Call May 05, 2022 09:00 AM ET Company Participants Matt Steinberg - Investor Relations, Lazar FINN Partners Sean Browne - President and Chief Executive Officer Scott Neils - Interim Chief Financial Officer Presentation Operator G...
Xtant Medical press release (NYSE:XTNT): Q1 GAAP EPS of -$0.03. Revenue of $13M (+3.7% Y/Y). For further details see: Xtant Medical GAAP EPS of -$0.03, revenue of $13M
BELGRADE, Mont., May 05, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31,...
Xtant Medical (NYSE:XTNT) has appointed Scott Neils as Chief Financial Officer, effective June 1, 2022. Neils served as interim CFO of the company most recently. He holds over 15 years of experience focused on public accounting and corporate finance. For further details see: Xtant Medic...
BELGRADE, Mont., May 02, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Chief Financial Officer, effective...
News, Short Squeeze, Breakout and More Instantly...
Xtant Medical Holdings Inc. Company Name:
XTNT Stock Symbol:
NYSE Market:
Xtant Medical Holdings Inc. Website:
BELGRADE, MT / ACCESSWIRE / May 22, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief...
Expects Revenue for Full Year 2024 of $116 Million to $120 Million BELGRADE, MT / ACCESSWIRE / May 15, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial a...
BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2...